Related references
Note: Only part of the references are listed.Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1/STAT3/ERK1/2 and adenylate cyclase/PKA, respectively
Mauro Sola-Penna et al.
BRITISH JOURNAL OF CANCER (2020)
Mammary Adipose Tissue Control of Breast Cancer Progression: Impact of Obesity and Diabetes
Vittoria D'Esposito et al.
FRONTIERS IN ONCOLOGY (2020)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The Role of 5-HT1A Receptor in Cancer as a New Opportunity in Medicinal Chemistry
Angela Corvino et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
Hitisha K. Patel et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids?
Georgios A. Kanakis et al.
Oncotarget (2018)
Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells
Maria Rosaria Ambrosio et al.
ONCOTARGET (2017)
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
William D. Gwynne et al.
ONCOTARGET (2017)
New 5-HT1A, 5HT2A and 5HT2C receptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluation
Ferdinando Fiorino et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
An in vitro model for the development of acquired tamoxifen resistance
Gamze Guney Eskiler et al.
CELL BIOLOGY AND TOXICOLOGY (2016)
Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus
Ferdinando Fiorino et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Elección del mejor antidepresivo en pacientes con cáncer de mama en tratamiento con tamoxifeno: revisión de la evidencia básica y clínica
María Elisa Irarrázaval O et al.
REVISTA MEDICA DE CHILE (2016)
Revisiting the drug interaction between tamoxifen and SSRI antidepressants
David Juurlink
BMJ-BRITISH MEDICAL JOURNAL (2016)
Revisiting the drug interaction between tamoxifen and SSRI antidepressants
David Juurlink
BMJ-BRITISH MEDICAL JOURNAL (2016)
Serotonin and Cancer: What Is the Link?
D. Sarrouilhe et al.
CURRENT MOLECULAR MEDICINE (2015)
New potent 5-HT2A receptor ligands containing an N′-cyanopicolinamidine nucleus: Synthesis and in vitro pharmacological evaluation
Ferdinando Fiorino et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Connective tissue growth factor in tumor pathogenesis
Annica Jacobson et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents
Ferdinando Fiorino et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Expanded Biology of Serotonin
Miles Berger et al.
ANNUAL REVIEW OF MEDICINE (2009)
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival
Vaibhav P. Pai et al.
BREAST CANCER RESEARCH (2009)
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression
N. Lynn Henry et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions
Malinda A. Stull et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin
B Sonier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Serotonergic regulation of somatosensory cortical development: Lessons from genetic mouse models
XY Luo et al.
DEVELOPMENTAL NEUROSCIENCE (2003)
Molecular, pharmacological and functional diversity of 5-HT receptors
D Hoyer et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Share Paper
